Alyeska Investment Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-200,000
| Closed | -$18.6M | – | 726 |
|
|
2021
Q4 | $18.6M | Buy |
+200,000
| New | +$13.2M | 0.21% | 141 |
|
|
2021
Q3 | – | Sell |
-268,661
| Closed | -$18.3M | – | 868 |
|
|
2021
Q2 | $18.3M | Buy |
268,661
+100,575
| +60% | +$6.56M | 0.21% | 140 |
|
|
2021
Q1 | $11.7M | Sell |
168,086
-165,874
| -50% | -$12.8M | 0.15% | 186 |
|
|
2020
Q4 | $25.7M | Buy |
333,960
+48,993
| +17% | +$3.67M | 0.36% | 83 |
|
|
2020
Q3 | $21.3M | Sell |
284,967
-179,157
| -39% | -$11.9M | 0.32% | 96 |
|
|
2020
Q2 | $29.2M | Sell |
464,124
-349,882
| -43% | -$19.3M | 0.44% | 66 |
|
|
2020
Q1 | $34.2M | Buy |
814,006
+49,630
| +6% | +$2.28M | 0.68% | 52 |
|
|
2019
Q4 | $34.7M | Buy |
764,376
+132,843
| +21% | +$6.28M | 0.46% | 78 |
|
|
2019
Q3 | $28.9M | Buy |
631,533
+123,547
| +24% | +$6.94M | 0.42% | 85 |
|
|
2019
Q2 | $29.8M | Sell |
507,986
-213,779
| -30% | -$11M | 0.38% | 88 |
|
|
2019
Q1 | $32.4M | Sell |
721,765
-69,533
| -9% | -$3.19M | 0.43% | 78 |
|
|
2018
Q4 | $30.8M | Sell |
791,298
-299,573
| -27% | -$11.8M | 0.45% | 82 |
|
|
2018
Q3 | $50.2M | Sell |
1,090,871
-120,929
| -10% | -$4.9M | 0.55% | 65 |
|
|
2018
Q2 | $52.8M | Buy |
1,211,800
+527,863
| +77% | +$22.7M | 0.47% | 79 |
|
|
2018
Q1 | $27M | Buy |
683,937
+145,689
| +27% | +$5.67M | 0.22% | 133 |
|
|
2017
Q4 | $18.3M | Buy |
+538,248
| New | +$15.3M | 0.15% | 171 |
|
Alyeska Investment Group's ARNA Position: Q1 2022 in Review
Alyeska Investment Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 200,000 shares — an estimated $18.6M sold.
Alyeska Investment Group first reported a position in ARNA in Q4 2017 and held it in 16 quarters. The position peaked at $52.8M in Q2 2018. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Alyeska Investment Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Alyeska Investment Group sold 200,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $18.6M.
- Alyeska Investment Group first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 16 quarters.
- Alyeska Investment Group's Arena Pharmaceuticals Inc position peaked at $52.8M in Q2 2018.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Alyeska Investment Group's 13F filing for Q1 2022, filed 16 May 2022.